ロード中...
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
Histological subtyping and grading by malignancy are the cornerstones of the World Health Organization (WHO) classification of tumors of the central nervous system. They shall provide clinicians with guidance as to the course of disease to be expected and the choices of treatment to be made. Nonethe...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3480248/ https://ncbi.nlm.nih.gov/pubmed/23095825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos206 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|